SUMMIT HEALTHCARE REIT, INC.: 10-Q filed 2012-08-14

Name: SUMMIT HEALTHCARE REIT, INC.: 10-Q filed 2012-08-14
Creator: SUMMIT HEALTHCARE REIT, INC.

What SUMMIT HEALTHCARE REIT, INC. reported in its quarterly report filed 2012-08-14 (fiscal Q2 2012): 22 published measures, 70 facts as tagged in accession 0001144204-12-045680.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-08-14
Fiscal period: fiscal Q2 2012
Accession: 0001144204-12-045680 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SUMMIT HEALTHCARE REIT, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-06-30	59,317,000	USD
At 2011-12-31	70,124,000	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-06-30	17,306,000	USD
At 2011-12-31	24,498,000	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-06-30	44,426,000	USD
At 2011-12-31	47,513,000	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-06-30	7,967,000	USD
At 2011-12-31	17,483,000	USD
At 2011-06-30	1,544,000	USD
At 2010-12-31	2,014,000	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-1,695,000	USD	91
2012-01-01 to 2012-06-30	-4,075,000	USD	182
2011-04-01 to 2011-06-30	-44,887,000	USD	91
2011-01-01 to 2011-06-30	-45,659,000	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-953,000	USD	91
2012-01-01 to 2012-06-30	-1,753,000	USD	182
2012-01-01 to 2012-03-31	-800,000	USD	91
2011-04-01 to 2011-06-30	-219,000	USD	91
2011-01-01 to 2011-06-30	262,000	USD	181
2011-01-01 to 2011-03-31	481,000	USD	90

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	1,084,000	USD	91
2012-01-01 to 2012-06-30	2,101,000	USD	182
2011-04-01 to 2011-06-30	1,256,000	USD	91
2011-01-01 to 2011-06-30	2,520,000	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	-7,659,000	USD	182
2011-01-01 to 2011-06-30	-9,292,000	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	-26,000	USD	182
2011-01-01 to 2011-06-30	8,560,000	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-06-30	-72,823,000	USD
At 2011-12-31	-68,748,000	USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	23,028,284	shares	91
2012-01-01 to 2012-06-30	23,028,284	shares	182
2011-04-01 to 2011-06-30	23,521,838	shares	91
2011-01-01 to 2011-06-30	23,473,816	shares	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-1,638,000	USD	91
2012-01-01 to 2012-06-30	-2,605,000	USD	182
2011-04-01 to 2011-06-30	-25,748,000	USD	91
2011-01-01 to 2011-06-30	-26,437,000	USD	181

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	167,000	USD	91
2012-01-01 to 2012-06-30	433,000	USD	182
2011-04-01 to 2011-06-30	320,000	USD	91
2011-01-01 to 2011-06-30	611,000	USD	181

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	0	USD	182
2011-01-01 to 2011-06-30	369,000	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-06-30	23,028,285	shares
At 2011-12-31	23,028,285	shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2012-06-30	42,011,000	USD
At 2011-12-31	45,626,000	USD
At 2011-06-30	53,962,000	USD
At 2010-12-31	100,970,000	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-1,920,000	USD	91
2012-01-01 to 2012-06-30	-4,603,000	USD	182
2011-04-01 to 2011-06-30	-44,939,000	USD	91
2011-01-01 to 2011-06-30	-45,711,000	USD	181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	698,000	USD	91
2012-01-01 to 2012-06-30	1,732,000	USD	182
2011-04-01 to 2011-06-30	755,000	USD	91
2011-01-01 to 2011-06-30	1,371,000	USD	181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	300,000	USD	91
2012-01-01 to 2012-06-30	700,000	USD	182
2011-04-01 to 2011-06-30	700,000	USD	91
2011-01-01 to 2011-06-30	1,400,000	USD	181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	770,000	USD	182
2011-01-01 to 2011-06-30	1,549,000	USD	181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	2,000	USD	91
2012-01-01 to 2012-06-30	4,000	USD	182
2011-04-01 to 2011-06-30	35,000	USD	91
2011-01-01 to 2011-06-30	93,000	USD	181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	174,000	USD	182
2011-01-01 to 2011-06-30	190,000	USD	181

Inspect the source

Entity: SUMMIT HEALTHCARE REIT, INC. / CIK 0001310383
Captured: 2026-09-21T17:18:56.284Z
SEC response SHA-256: d84433c298f19972258718faa5de37031e5853feef78fdb86fc96c679743a5b5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001310383.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))